Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

It’s More than PPE – Infection Control in Different Facility Settings

By Marcy Hahn-Saperstein on April 10, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

Facing unprecedented community spread of the 2019 Novel Coronavirus Disease (COVID-19), the Centers for Medicare and Medicaid Services (CMS) has provided additional guidance to a variety of health care providers that is designed to minimize further transmission of the disease. CMS responds to frequently asked questions related to the logistics for minimizing transmission of COVID-19 in various patient settings. Specifically, on April 8, CMS issued three separate memoranda to State Survey Agency Directors (collectively, the “Guidance”) regarding infection control and transmission prevention of COVID-19 in three different settings: (i) Hospitals, Psychiatric Hospitals and Critical Access Hospitals: (ii) Outpatient Settings; and (iii) Intermediate Care facilities for Individuals with Intellectual Disabilities and Psychiatric Residential Treatment Facilities.

In general, the Guidance advises all providers to contact their local health department if they suspect a patient or personnel is infected with COVID-19. They should monitor personnel who have exposure to patients with known or suspected COVID-19 and maintain a plan for how such exposed or infected personnel may return to work.  Each memorandum is based on frequently asked questions pertaining to the type of patient setting.  The subject matter covered in each memorandum is set forth below.

Hospitals, Psychiatric Hospitals and Critical Access Hospitals

The Guidance relevant to these hospitals can be found here.

This Guidance pertaining to hospitals provides answers to a wide variety of questions, including:

  • the process for allowing exposed healthcare personnel to return to work where testing is available and where it is not available;
  • additional measures to be implemented to mitigate hospital transmission in hospital outpatient settings;
  • additional measures to be implemented to mitigate transmission in inpatient settings;
  • scenarios that militate in favor of admitting patients in different settings to temporarily expand bed capacity;
  • COVID-19 screening processes for visitors, patients and staff;
  • special instructions for organ donation;
  • special considerations for discharge of patients with COVID-19; and
  • strategies for limiting visitors.

Outpatient Facility Settings

The Guidance relevant to outpatient facilities can be found here.

This Guidance related to outpatient facilities restates prior CMS recommendations to delay elective surgeries and procedures and encourages outpatient facilities to work with the communities in which they are located to redistribute PPE, bed capacity and ventilators when possible. The Guidance pertaining to outpatient facilities provides answers to a wide variety of questions, including:

  • identifying those patients at greatest risk and actions to facilitate early recognition and management of patients, staff and visitors;
  • directing outpatient facilities to follow CDC guidelines governing criteria for COVID-19 exposed health care staff to return to work, which guidelines can be found here;
  • restricting visitors;
  • handling disinfection of environmental surfaces, medical devices and equipment;
  • clarifications regarding closures;
  • waivers of health and safety requirements; and
  • logistics for dealing with a scarcity of supplies; including clarifications regarding the use of certain respirators.

Intermediate Care Facilities for Individuals with Disabilities/Psychiatric Residential Treatment Facilities

The Guidance relevant to Intermediate Care Facilities for Individuals with Disability and Psychiatric Residential Treatment Facilities can be found here.

The Guidance related to these facilities provides answers to a wide variety of questions, including:

  • the applicability of specific and blanket waivers to various requirements;
  • strategies for addressing staffing shortages by combining facilities and dealing with bed capacity flexibility;
  • strategies for addressing client and staff exposure;
  • strategies for handling community activities;
  • modifications to client’s programs to manage transmission;
  • flexibility to utilize alternate care models and facilities;
  • balancing CDC expectations with individual patient rights;
  • logistics for screening visitors and outside health care providers;
  • accepting as clients COVID-19 diagnosed hospital patients;
  • logistics for dealing with a scarcity of supplies.

Summary

The Guidance reminds providers that the situation is evolving rapidly and that recommendations from CMS, the CDC and other agencies are likely to change, as well.

Photo of Marcy Hahn-Saperstein Marcy Hahn-Saperstein

With a background in healthcare finance and as in-house counsel to a hospital, Marcy Hahn-Saperstein now serves as outside general counsel to hospitals and other healthcare providers. In this capacity, she structures, drafts, negotiates, and performs regulatory analyses for, corporate transactions, including equity…

With a background in healthcare finance and as in-house counsel to a hospital, Marcy Hahn-Saperstein now serves as outside general counsel to hospitals and other healthcare providers. In this capacity, she structures, drafts, negotiates, and performs regulatory analyses for, corporate transactions, including equity and asset purchases, mergers, restructurings, and joint venture arrangements. On behalf of healthcare providers, Marcy drafts and negotiates physician practice acquisitions, facility and equipment leases, professional services and management agreements, and other agreements that arise in the operation of their business. She also assists her clients with licensing issues, including obtaining approvals from regulatory agencies necessitated by M&A-related changes of ownership, and she counsels clients on corporate governance matters.

Read more about Marcy Hahn-SapersteinEmail
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Rx
  • Organization:
    Akerman LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo